Latest Mammography Stories

Angelina Jolie's courage to undergo breast cancer preventive double mastectomy creates headlines and the opportunity for greater awareness on the issue. Doctors of Physical Therapy help patients regain function and proper movement after the mastectomy -From Hands-On News. Astoria, NY (PRWEB) May 16, 2013 Over 230,000 women are diagnosed every year with invasive breast cancer as reported by the American Cancer Society. Mammograms, clinical breast exams and self-breast exams are some...

Insurance coverage for annual screening likely one reason for persistence Women in their 40s continue to undergo routine breast cancer screenings despite national guidelines recommending otherwise, according to new Johns Hopkins research. In 2009, the U.S. Preventive Services Task Force (USPSTF) sifted through the evidence and recommended that while women ages 50-74 should continue to undergo mammograms every two years, those between the ages of 40 and 49 without a family history of...

Search, Share, Spare Campaign Addresses Knowledge Gaps SAN FRANCISCO, May 15, 2013 /PRNewswire/ -- Studies have shown nearly 70 percent of patients with breast cancer do not discuss all surgical options with their surgeon before their initial surgery and that such a discussion significantly affects a woman's treatment decision(1). To address this knowledge gap, the Search, Share, Spare campaign launched today to raise awareness about surgery options that spare a woman's breast...

Digital direct radiography (DR) is significantly more effective than computed radiography (CR) at detecting breast cancer, according to a new study published online, May 14, in the journal Radiology. Oak Brook, Ill. (PRWEB) May 13, 2013 Digital direct radiography (DR) is significantly more effective than computed radiography (CR) at detecting breast cancer, according to a new study published online in the journal Radiology. The findings are the first to show a difference between the two...

Members Share Stories of Healing and Healthy Living OAKLAND, Calif., May 13, 2013 /PRNewswire/ -- When Wende King went in for a routine ultrasound at 23 weeks pregnant, she wasn't expecting to stay. But during the examination, her Kaiser Permanente physician told Wende that she would have to be monitored at the hospital until the babies were born. Wende and her husband were scared. "The statistics for a premature baby born at 23 weeks and a day were very grim," Wende said. "It...

After her diagnosis and treatment for ovarian cancer, Shannon Miller was worried she wouldn't be able to have another child. Today, cancer-free and pregnant, she's helping Turn The Towns Teal® to raise awareness about the disease. Brookside, NJ (PRWEB) May 07, 2013 After Shannon Miller, the most decorated gymnast in U.S. history, was diagnosed with ovarian cancer two-and-a-half years ago, she was worried she may not be able to have more children. “There was always that...

Nationally recognized, breast center continues commitment to 100% early detection of breast cancer with the addition of breast tomosynthesis. Montclair, NJ (PRWEB) May 02, 2013 Montclair Breast Center is one of the first women’s centers in New Jersey to offer 3D mammography (breast tomosynthesis) for breast cancer screening. Breast tomosynthesis produces a three-dimensional view of the breast tissue that helps radiologists identify and characterize individual breast structures without...

GARDEN CITY, N.Y., May 2, 2013 /PRNewswire/ -- Millennium HealthCare Inc. (OTC Pink: MHCC) today announced that its Medical Device subsidiary signed an agreement with Atossa Genetics Inc. (NASDAQ: ATOS) for the distribution of Atossa's ForeCYTE Breast Health devices, which consist of the patented MASCT pump and ForeCYTE patient collection kits. Millennium has submitted an initial order for 10,000 ForeCYTE collection kits, which it intends to market to managed-care networks,...

Accurate, Rapid, Cost-Effective Blood Test Aims to Confirm True Negative Findings While Halving the Rate of False Negative Mammography Results MIAMI, May 2, 2013 /PRNewswire/ -- Eventus Diagnostics, Inc. (EventusDx) today announced that it has received CE mark designation for its Octava Pink(TM) breast cancer test intended for confirmatory use in women who have received negative mammography results. The National Cancer Institute (NCI) estimates that screening mammograms miss about...

Addition of tomosynthesis increased breast cancer detection and simultaneously reduced recall rates BEDFORD, Mass., May 1, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products with an emphasis on serving the healthcare needs of women, today announced the publication of the final results of a large-scale prospective study comparing breast cancer...